Alternatives to Exemestane If You Can't Fill Your Prescription

Exemestane (Aromasin) is an effective treatment for hormone receptor-positive breast cancer — but when you can't fill your prescription, waiting is not a safe option. If you've exhausted your pharmacy options and can't find exemestane in stock, it's time to have a conversation with your oncologist about alternatives.

Important: Do not switch medications or stop taking hormonal therapy without speaking to your oncologist first. The alternatives described here require a new prescription, and your doctor needs to evaluate whether a switch is clinically appropriate for your specific situation.

Why Exemestane Is Sometimes Irreplaceable

Exemestane is the only steroidal aromatase inhibitor (AI) approved by the FDA. Unlike anastrozole and letrozole, which are nonsteroidal and reversibly block the aromatase enzyme, exemestane permanently inactivates it. This makes exemestane the drug of choice when:

• You've already failed or been unable to tolerate anastrozole or letrozole
• You're switching from 2–3 years of tamoxifen to complete a 5-year course of hormonal therapy
• Your oncologist has a specific clinical reason to prefer a steroidal AI in your case

In these cases, switching to a nonsteroidal AI may not be equivalent. However, for many patients who are using exemestane as their first-line AI, switching to anastrozole or letrozole may be an option your oncologist considers reasonable.

Alternative 1: Anastrozole (Arimidex)

Anastrozole is the most widely prescribed aromatase inhibitor in the U.S. It's a nonsteroidal AI that reversibly blocks the aromatase enzyme, reducing estrogen levels by approximately 80% at the standard 1 mg daily dose.

Key facts about anastrozole:

• Dose: 1 mg oral tablet once daily, with or without food
• Availability: Widely stocked at virtually all pharmacies; generic available
• Cost: Often under $5–$10/month with a GoodRx discount — significantly cheaper than exemestane
• Side effects: Similar to exemestane — hot flashes, joint pain, bone loss — but may cause more cholesterol elevation
• Cross-resistance: Because anastrozole and exemestane work differently (nonsteroidal vs. steroidal), they are only partially cross-resistant — meaning some patients respond to exemestane after failing anastrozole, and vice versa

Alternative 2: Letrozole (Femara)

Letrozole is another nonsteroidal aromatase inhibitor. It's often considered the most potent of the three AIs, suppressing estrogen levels by more than 99% in clinical studies. Like anastrozole, letrozole is widely available and inexpensive.

Key facts about letrozole:

• Dose: 2.5 mg oral tablet once daily, with or without food
• Availability: Excellent — one of the most commonly stocked oncology drugs
• Cost: Often under $5–$6/month with a GoodRx discount
• Side effects: Similar to anastrozole — hot flashes, bone loss, joint pain; tends to cause slightly less cholesterol elevation than anastrozole
• A large French study (published 2025 in JAMA Network Open) found anastrozole and letrozole had slightly better 8-year disease-free survival than exemestane — making either a reasonable first-line choice

Alternative 3: Fulvestrant (Faslodex)

Fulvestrant is a selective estrogen receptor degrader (SERD) — a different class of drug entirely. Rather than blocking estrogen production, it works by degrading the estrogen receptor itself. It's FDA-approved for hormone receptor-positive metastatic breast cancer.

Key facts about fulvestrant:

• Administration: Intramuscular injection given once monthly (two 5 mL injections — one in each buttock)
• Primarily used for: Advanced or metastatic breast cancer, often after AI failure
• Less likely to be used as a direct swap for exemestane in early breast cancer settings

Alternative 4: Tamoxifen (Nolvadex)

Tamoxifen is a selective estrogen receptor modulator (SERM) — it blocks estrogen's ability to stimulate breast cancer cells, but unlike aromatase inhibitors, it doesn't lower estrogen levels. Tamoxifen can be used in both pre- and postmenopausal women and is sometimes the drug that patients take before switching to exemestane.

For postmenopausal women currently on exemestane, switching back to tamoxifen is generally not the preferred approach. But it may be considered in specific clinical situations, particularly when an AI is not well-tolerated.

How to Talk to Your Oncologist About Switching

When you call your oncologist's office, be direct: explain that you cannot find exemestane in stock at any nearby pharmacy and ask what they recommend. Key questions to ask:

• "Is switching to anastrozole or letrozole clinically appropriate for my case?"
• "If I miss a few days of exemestane while I locate it, how concerned should I be?"
• "Can your office help me find exemestane through a hospital pharmacy or specialty supplier?"

The Bottom Line

Before switching medications, exhaust your options to find exemestane. Read our guide on how to find exemestane in stock near you, or use medfinder.com to have pharmacies near you checked on your behalf. If you genuinely cannot find it, talk to your oncologist about the alternatives described above.